COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #54
Source   PDF   Share   Tweet
See all 143 studies
6/10
Inconc.
Late treatment study
Wang et al., medRxiv, doi:10.1101/2020.06.11.20128926 (Peer Reviewed)
Comorbidity and Sociodemographic determinants in COVID-19 Mortality in an US Urban Healthcare System
Database analysis of 7,592 patients in NYC, showing adjusted HC Q mortality odds ratio OR 0.96, p = 0.82, and HC Q+AZ OR 0.94, p = 0.63
death, ↓5.8%, p=0.63
(odds ratio converted to relative risk)
Source   PDF   Share   Tweet
See all 143 studies
Please send us corrections, updates, or comments.
Submit